Kline & Specter has litigated and is currently handling multiple prostate cancer cases. With more than 30 attorneys, five of whom are also doctors, we have the expertise to handle your prostate cancer lawsuit. In one case, a patient had a recurrence of prostate cancer and ultimately died due to a delayed diagnosis. In another case, a patient’s blood test showed a high level of prostate-specific antigen—or PSA—that was missed by his doctors, resulting in a years-long delayed diagnosis. PSA is a substance produced by the prostate gland and is normally secreted into the bloodstream in small amounts. Increased levels of PSA can be a signal that the prostate gland is infected, enlarged or malignant.
Since prostate cancer may not exhibit obvious symptoms in its early stages, prostate screening is the best chance for early detection. Screening tests include a prostate-specific antigen (PSA) blood test and digital rectal exam. These tests are usually performed during an annual physical examination in men older than 50. If PSA levels are unusually elevated, additional testing may be required. Men who have a family history of prostate cancer are at an increased risk of developing the disease and may choose to start regular screenings as young as 40. Men who smoke and consume a high-fat diet also have a greater chance of developing prostate cancer.
When symptoms of prostate cancer do appear, the American Cancer Society recommends getting tested by your doctor. Symptoms may include:
- Urination problems – slow or weak flow, inability to urinate, loss of bladder control or the need to urinate more often, particularly at night
- Blood in urine or semen
- Erectile dysfunction
- Pain or burning during urination
- Pain in the spine, ribs, hips or pelvis
- Numbness or weakness in the feet or legs
If you or a loved one suffered severe injury or death due to a delayed or missed diagnosis of prostate cancer, call 800-243-1100 or contact a prostate cancer lawyer for a free evaluation of your case. Kline & Specter represents clients in Pennsylvania, New Jersey, Delaware and nationwide.
